Skip to content
PIL Logo

NutropinAq 10mg/2mL

Last Updated on eMC 08-Apr-2016 View document  | Ipsen Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08-Apr-2016 and displayed until Current

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision

Updated on 23-Apr-2014 and displayed until 08-Apr-2016

Reasons for adding or updating:

  • Change to section 4 - how to report a side effect

Updated on 04-Jul-2013 and displayed until 23-Apr-2014

Reasons for adding or updating:

  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 19-Mar-2012 and displayed until 04-Jul-2013

Reasons for adding or updating:

  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications

Updated on 14-Jun-2011 and displayed until 19-Mar-2012

Reasons for adding or updating:

  • Change to date of revision
  • Change to MA holder contact details

Updated on 04-May-2011 and displayed until 14-Jun-2011

Reasons for adding or updating:

  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects

Updated on 15-Jan-2010 and displayed until 04-May-2011

Reasons for adding or updating:

  • Change to date of revision
  • Correction of spelling/typing errors
  • Change of licence holder

Updated on 21-Oct-2009 and displayed until 15-Jan-2010

Reasons for adding or updating:

  • Improved Electronic Presentation

Updated on 09-Jun-2008 and displayed until 21-Oct-2009

Reasons for adding or updating:

  • Transfer to upgraded management system

Updated on 07-Feb-2007 and displayed until 09-Jun-2008

Reasons for adding or updating:

  • Change due to harmonisation of patient information leaflet

Updated on 01-Apr-2005 and displayed until 07-Feb-2007

Reasons for adding or updating:

  • Change to warnings or special precautions for use

Updated on 29-Mar-2004 and displayed until 01-Apr-2005

Reasons for adding or updating:

  • New PIL for new product

Company contact details

Ipsen Ltd

Company image
Address

190 Bath Road, Slough, Berkshire, SL1 3XE

Fax

+44 (0)1753 627 778

Medical Information e-mail
Telephone

+44 (0)1753 627 777

Medical Information Direct Line

+44 (0)1753 627 777

Customer Care direct line

+44 (0)1753 627 627

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

somatropin

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue